Efficacy, Safety and Predictive Factors for Outcomes and Adverse Events in Sclerotherapy for Venous Malformations in Children
Author / Expert
Niclas Schmitt, Julia Lorenz, Lena Wucherpfennig, Kianush Karimian-Jazi, Fabian Ruping, Oliver Ristow, Jürgen Hoffmann, Patrick Günther, Martin Bendszus, Markus A. Möhlenbruch, Dominik F. Vollherbst
Topic overview
Percutaneous sclerotherapy is an established treatment for venous malformations (VM), while data on its use in children remain limited. This study aimed to evaluate the efficacy, safety and predictors of clinical outcome and adverse events (AEs) in children undergoing polidocanol-based sclerotherapy of VMs.
Comments